CD4 and glioblastoma: Our results revealed that immune/stroma scores were significantly higher in both TSPAN29/30 high expression groups, suggesting that they may affect the tumor immune microenvironment in GBM by regulating pattern recognition, antigen presentation, and T-cell activation (TSPAN29 positively correlated with Tfh and negatively correlated with CD4 + memory T cells).